Niklas Ekman PhD

Dr. Niklas Ekman has a background in molecular cell and cancer biology. After joining the Finnish Medicines Agency (FIMEA) in late 2006, he worked the next 11 years as a quality assessor for biological medicinal products. His main activities and responsibilities included assessments of European Medicines Agency (EMA) centralized marketing authorization applications, scientific advice, as well as national clinical trial applications. Currently, Dr. Ekman is the head of the biological section at the Finnish Medicines Agency.